Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thoralf Christoffersen

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Experimental & Clinical Cancer Research : CR|July 31, 2016
The TGFβ-SMAD3 pathway inhibits IL-1α induced interactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migrationVegard Tjomsland, Dagny Sandnes, Ewa Pomianowska, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|February 21, 2008
A study of phosphorylated ERK1/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomasTine M Søland, Camilla Husvik, Hanna Strømme Koppang, et al.
BMC Cancer|June 11, 2014
Inhibitory effects of prostaglandin E2 on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinomaEwa Pomianowska, Dagny Sandnes, Krzysztof Grzyb, et al.
Journal of Cellular Physiology|July 27, 2007
Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytesOlav F Dajani, Kristin Meisdalen, Tormod K Guren, et al.
Oncotarget|October 15, 2016
Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancerMaria Thomsen, Christian Kersten, Halfdan Sorbye, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2017
Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation statusMaria Thomsen, Marianne Grønlie Guren, Eva Skovlund, et al.
British Journal of Cancer|June 7, 2018
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcomeMaria Thomsen, Eva Skovlund, Halfdan Sorbye, et al.
British Journal of Cancer|April 12, 2017
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII studyTormod Kyrre Guren, Maria Thomsen, Elin H Kure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII studyKjell Magne Tveit, Tormod Guren, Bengt Glimelius, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Experimental & Clinical Cancer Research : CR|July 31, 2016
The TGFβ-SMAD3 pathway inhibits IL-1α induced interactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migrationVegard Tjomsland, Dagny Sandnes, Ewa Pomianowska, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|February 21, 2008
A study of phosphorylated ERK1/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomasTine M Søland, Camilla Husvik, Hanna Strømme Koppang, et al.
BMC Cancer|June 11, 2014
Inhibitory effects of prostaglandin E2 on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinomaEwa Pomianowska, Dagny Sandnes, Krzysztof Grzyb, et al.
Journal of Cellular Physiology|July 27, 2007
Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytesOlav F Dajani, Kristin Meisdalen, Tormod K Guren, et al.
Oncotarget|October 15, 2016
Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancerMaria Thomsen, Christian Kersten, Halfdan Sorbye, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2017
Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation statusMaria Thomsen, Marianne Grønlie Guren, Eva Skovlund, et al.
British Journal of Cancer|June 7, 2018
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcomeMaria Thomsen, Eva Skovlund, Halfdan Sorbye, et al.
British Journal of Cancer|April 12, 2017
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII studyTormod Kyrre Guren, Maria Thomsen, Elin H Kure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII studyKjell Magne Tveit, Tormod Guren, Bengt Glimelius, et al.
Pageof 4